Borstelmann, Nancy A.
Gray, Tamryn F.
Gelber, Shari
Rosenberg, Shoshana
Zheng, Yue
Meyer, Meghan
Ruddy, Kathryn J.
Schapira, Lidia
Come, Steven
Borges, Virginia
Cadet, Tamara
Maramaldi, Peter
Partridge, Ann H.
Funding for this research was provided by:
Susan G. Komen
Breast Cancer Research Foundation
The Pink Agenda
Article History
Received: 24 September 2021
Accepted: 19 January 2022
First Online: 28 January 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board committee (IRB) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by IRBs of the Dana-Farber Harvard Cancer Center, Simmons University, and 12 other participating sites (Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Cape Cod Hospital, Faulkner Hospital, Lowell General Hospital, Massachusetts General Hospital, Mayo Clinic, Newton-Wellesley Hospital, North Shore Cancer Center Salem, South Shore Hospital, Sunnybrook Health Sciences Centre, and University of Colorado Hospital).
: Informed consent was obtained from all individual participants included in the study.
: The authors affirm that human subject research participants provided informed consent for publication of their deidentified data.
: The authors declare no competing interests.